Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Completed 3Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2FED 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 22Other hematologic neoplasm 13Gastrointestinal 9Lymphoid 8Gynecologic 6Genitourinary 6CNS 6Tumor-Agnostic 5Thoracic 5Other solid neoplasm 5Head & Neck 5Plasma cell 4Dermatologic 4Sarcoma 3Other 2Myeloid 2Classical hematology 1

Conditions

Prostatic Neoplasms 3Urinary Bladder Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Localized Prostate Cancer 1Insulin Resistance 1Head and Neck Neoplasms 1Erectile Dysfunction 1Carcinoma, Renal Cell 1Adenocarcinoma of Lung 1

Interventions

Docetaxel 409pembrolizumab 331Prednisone 289enzalutamide 283Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 252Abiraterone Acetate 217Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 117Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 106cabozantinib 104atezolizumab 104Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Tablets × Genitourinary × Clear all
NCT06966778 2026-03-16

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

National Taiwan University Hospital

Phase NA Recruiting
135 enrolled
Genitourinary

Localized Prostate Cancer

NCT05265988 2024-07-31

MERIDIAN

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Completed
32 enrolled
Genitourinary

Prostatic Neoplasms

NCT04658849 2023-05-15

Insulin Resistance Following ADT for Prostate CA

St. Louis University

Phase EARLY_PHASE1 Withdrawn
Genitourinary

Insulin Resistance, Prostatic Neoplasms

NCT01976741 2021-05-06

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Bayer

Phase 1 Completed
168 enrolled 59 charts
GenitourinaryHead & NeckThoracic

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms

NCT01865747 2021-04-27

METEOR

Exelixis

Phase 3 Completed
658 enrolled 15 charts
Genitourinary

Carcinoma, Renal Cell

NCT03406169 2018-01-23

Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy

Brooke Army Medical Center

Phase 3 Unknown
180 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡